We have reported previously that arginine-induced insulin secretion was impaired in the vitamin D-deficient rat pancreas, and that it was improved by dietary vitamin D repletion (Norman, A. W., B. J. Frankel, A. M. Heldt, and G. M. Grodsky, 1980, Science [Wash. DC]. 209:823-825). In this study, we evaluate in the perfused rat pancreas system whether the effects of vitamin D and its metabolites on insulin secretion are direct in action on the pancreas and limited to the secretagogue arginine, or whether they are secondary to the hypocalcemia or reduced caloric and calcium intake associated with vitamin D deficiency. In an experiment where vitamin D-replete (+D) rats were pair-fed to D-deficient (-D) rats fed ad lib., the secretion of insulin in response to arginine infusion in the +D perfused rat pancreas was threefold higher than in the -D control. In a second experiment, the serum calcium level was elevated from the characteristic hypocalcemic level of -D rats (4.9 +/-0.1 mg/dl) to a normal calcemic level (10.0 +/-0.3 mg/dl) by feeding the rats a -D diet with dietary calcium levels ranging from 0.4 to 4%. In these -D rats, the pancreatic perfusion study with the secretagogue arginine showed a similar blunted insulin secretion response in all groups in spite of the significant differences of serum calcium levels. [823][824][825]. In this study, we evaluate in the perfused rat pancreas system whether the effects of vitamin D and its metabolites on insulin secretion are direct in action on the pancreas and limited to the secretagogue arginine, or whether they are secondary to the hypocalcemia or reduced caloric and calcium intake associated with vitamin D deficiency. In an experiment where vitamin D-replete (+D) rats were pair-fed to Ddeficient (-D) rats fed ad lib., the secretion of insulin in response to arginine infusion in the +D perfused rat pancreas was threefold higher than in the -D control. In a second experiment, the serum calcium level was elevated from the characteristic hypocalcemic level of -D rats (4.9±0.1 mg/dl) to a normal calcemic level (10.0±0.3 mg/dl) by feeding the rats a -D diet with dietary calcium levels ranging from 0.4 to 4%. In these -D rats, the pancreatic perfusion study with the secretagogue arginine showed a similar blunted insulin secretion response in all groups in spite of the significant differences of serum calcium levels. In a third experiment, insulin secretion in response to the separate administration of arginine (10 mM), glucose (16.9 mM), and tolbutamide (0.37 mM) was found to be significantly higher in pair-fed, normocalcemic +D rats than in -D rats with normal calcium 
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Introduction
In recent years, there have appeared several reports which suggest that the endocrine pancreas is also a target tissue for the hormonally active form of vitamin D3, 1,25-dihydroxyvitamin D3[1,25-(OH)2-D3]', along with the classical vitamin D target organs: the intestine, bone, and kidney (1). These observations include: (a) the presence of a cytosol receptor protein for 1,25-(OH)2-D3 in the chick pancreas (2-4); (b) the presence of immunoreactive vitamin D-dependent calcium binding protein (CaBP) in the chick (4), pig (5) , and rat (6) pancreas by radioimmunoassay and its dependency on dietary vitamin D3 (7); (c) immunohistochemical demonstration of CaBP in the endocrine B cells of chick (8) , cat (9) , dog (9), mice (9) , and rat (9) 
Methods
Male weanling rats, obtained from the Holtzman Co. (Madison, WI), were raised for 6-7 wk on a synthetic -D diet (0.4% Ca, 0.35% P) (14) . All animals were housed individually in stainless steel cages with a 12-h light, 12-h dark cycle free of UV light and were allowed free access to the diet and water. These animals were used in the following separate experiments. When vitamin D3 was provided, it was dissolved in 0.1 ml of a solvent (95% ethanol:1,2-propanediol, 1:1 vol) containing appropriate concentrations of vitamin D3, and subcutaneously injected. Vehicle alone (0.1 ml) was administered to the control group. Experiment 1. This experiment was designed to investigate the effect of vitamin D3 (4.55 nmol, 3 times per week) on the arginine (10 mM)-induced insulin secretion from the isolated perfused pancreas of rats that were fed either ad lib. or pair-fed with -D control rats given vehicle alone. Vitamin D supplementation with or without pair-feeding was continued at least for 3 wk after 5 wk of vitamin D depletion before starting the pancreatic perfusion study, according to the method described below.
The daily dietary intake of -D control rats was measured gravimetrically every day by using a commercial rat food device (Wahmann Manufacturing Co., Timonium, MD) and the mean dietary intake of these animals was given to the +D rats (scheduled to be pair-fed) the next day. Preliminary studies indicated that the daily dietary intake (mean±SEM) was 15±2, 30±4, and 15±3 g/d in the -D control rats fed ad lib. (n = 10), +D rats fed ad lib. (n = 10), and +D rats pair-fed with -D rats (n = 10), respectively. Experiment 2. This experiment was designed to evaluate how differing serum levels ofcalcium might affect the arginine-induced insulin secretion from the isolated perfused pancreas of the -D rat. Several levels of serum calcium from low (4.9 mg/dl) to normal (10.0 mg/dl) were established in -D rats by manipulating the dietary calcium composition (group 1, 0.4%; group 2, 1%; group 3, 2%; group 4, 4%) at the expense of cellulose. Also, the dietary composition of D-glucose (53.5%) was made constant among these groups. Groups 2-4 were pair-fed with group 1 according to the method described in experiment I until the day of perfusion. Experiment 3. This experiment was designed to evaluate the insulin secretion in response to the separate administration ofthe secretagogues arginine, glucose, or tolbutamide in the isolated perfused pancreas of +D rats (vitamin D3, 975 pmoVd subcutaneous) pair-fed with -D rats with a normal serum calcium effected by manipulating the dietary calcium composition (4% with pair-feeding). Vitamin D3 or vehicle alone was administered for 3-4 wk until the day of pancreatic perfusion. According to the results from experiment 2, normal serum calcium levels could be obtained in -D rats placed on the -D diet containing 4% calcium.
Perfusion system. The pancreas was isolated and perfused by the procedure described by Grodsky et al. (15) with minor modifications. Overnight fasted animals were anesthetized with chloral hydrate (300 mg/kg body weight intraperitoneal) and the surgical preparation was carried out according to the method described previously (16). All experiments were performed between 9:00 a.m. and 4:00 p.m. by using a pancreatic perfusion apparatus (KM-IA Type, Kokenrika Co., Ltd., Osaka, Japan). The entire surgical operation was finished within 20 min, and the pancreas was perfused at a flow rate of 2 ml/min with a KrebsRinger bicarbonate buffer, pH 7.4, containing 0.25% bovine serum albumin and 4.6% Dextran (Sigma Chemical Co., St. Louis, MO) equilibrated with 95% 02:5% CO2 at 37°C. After 15 min equilibration time with this medium, the insulin secretagogue (arginine, glucose, or tolbutamide) was introduced for 20 min from a side syringe to maintain a final concentration of 10 mM, arginine; 16.7 mM, glucose; or 0.37 mM, tolbutamide, respectively. In experiment 3, the secretagogues arginine (10 mM), glucose (16.7 mM), or tolbutamide (0.37 mM) were separately used to stimulate insulin secretions. The portal effluent was collected in fractions of 2.0-min duration and frozen until assayed for insulin. Blood samples (3 ml) were obtained from all rats undergoing the perfusion experiment through the jugular vein just before removal of the pancreas, and were collected in chilled heparinized tubes. After centrifugation, plasma was stored at -20°C until it was assayed for glucose, calcium, phosphate, and vitamin D metabolites.
Analytical method. Immunoreactive insulin was measured by a radioimmunoassay procedure by using antibody raised against porcine insulin, and rat insulin (Novo Research Institute, Copenhagen, Denmark) was used as a standard. The separation of free and bound hormone was carried out via utilization of dextran charcoal (17) . Plasma glucose was measured by glucose oxidase method (18) . Plasma total calcium value was determined by an atomic absorption method (19) and ionized calcium was measured by utilization of an ionized calcium analyzer Space-state 20 (Orion Research Inc., Cambridge, MA). Plasma phosphate value was determined by the method of Chen et al. (20) . Measurement of plasma 25-hydroxyvitamin D3 (25-OH-D3) and 1,254OH)2-D3 were performed as previously described (21) .
Results
Parameters of -D and +D rats (Table I) . Table I Effect of vitamin D repletion on arginine (10 mM)-glucose (5 mM)-induced insulin secretionfrom the isolatedperfusedpancreas of+D ratfed ad lib. or pair-fed with -D control rats (Fig.  1, Table I ). Fig. 1 presents the results of arginine (10 mM)-glucose (5 mM)-induced insulin secretion from the pancreas of groups 1 (-D, fed ad lib.), group 2 (+D, pair-fed to -D), and group 3 (+D, fed ad lib.); all groups had typical biphasic responses of insulin secretion in response to the infusion of arginine. In each group, the insulin response reached a maximum within 3 min of arginine-glucose stimulation followed by transient decreases towards 6 min (first phase) and after that, a sustained insulin release was observed until the end ofstimulation (second phase).
The maximum value of insulin secretion in the first phase of groups 1, 2, and 3 was 7.0±1.2, 21.5±4.2, and 31±4.0 ng/ ml, respectively (group 1 vs. 2, P < 0.005; group 2 vs. 3, P < 0.05). Insulin secretion in the second phase was also highest in group 3 followed by group 2 and group 1. Cumulative insulin secretion in the first and second phases was 40±6 and 70±1 1 Results are expressed as means±SEM of the indicated numbers. Groups 2-4 were pair-fed with group 1. Ionized Ca (Ca"+) and total Ca were measured in the same sample. * P < 0.05, * P < 0.01, significant difference from group 1. § P < 0.05, 1"P < 0.01, significant difference from group 2. ' P < 0.001, significant difference from group 3. 'D 4% Ca DIET repletion of these rats also produced normocalcemia (Table III) Arginine-stimulated insulin secretion was significantly higher in the +D group than the -D group (Fig. 3 A) . The peak values of the first phase of insulin secretion in the +D group was threefold higher than in the -D group (32±3.5 vs. 11.2+1.7, P < 0.001). Insulin release in the second phase also was twofold higher in the +D rats. These differences were also reflected in the cumulative insulin secretion as tabulated in Table III. In the instance of glucose stimulation, insulin response also exhibited a typical biphasic pattern. The peak value in the first phase appeared at 3 min, which was 2.3-fold higher in the +D group (13.5±2.1 vs. 5.2±0.5 ng/ml; P < 0.001). The differences of insulin secretion were more marked in the second phase; here, the cumulative insulin secretion in the first and second phase were about threefold and fivefold higher in +D groups (Table III; Fig. 3B) .
Tolbutamide stimulation demonstrated a typical monophasic insulin response showing peak value at 3 min. This peak value was also 2.3-fold higher in the +D group (13.1±0.8 vs. 5.6± 1.0 ng/ml, P < 0.001), while no significant difference was found in the second phase of insulin secretion. The cumulative insulin secretion in the first phase also showed a twofold higher value in the +D group, while no difference was found in the second phase (Table III; Fig. 3C ).
Discussion
The present results indicate (a) that normalization of serum calcium in -D rats does not normalize arginine-glucose-induced insulin secretion and (b) that equalization of dietary caloric intake between -D and +D rats does not abolish the effect of vitamin D on mediating insulin secretion. Thus, the present findings confirm our previous report ( 11) that arginine-glucoseinduced insulin secretion from the isolated perfused pancreas was significantly decreased in vitamin D deficiency and improved by dietary vitamin D repletion.
There are several direct and indirect factors known to affect insulin secretion after vitamin D repletion; these include: (a) increased dietary caloric and calcium intake; (b) increased levels of serum total and ionized calcium; (c) changes of hormonal environment, especially parathyroid hormone (PTH); (d) a genomic effect of the vitamin D metabolite, 1,25-(OH)2-D3, on pancreatic B cell, involving the production of vitamin D-dependent CaBP, which may influence intracellular calcium metabolism and enzyme activation; and (e) putative membrane effects ofvitamin D metabolite on pancreatic B cell. It is generally accepted that insulin release in response to glucose (22) (23) (24) and amino acids (25, 26) B cell function during vitamin D deficiency. However, Rebodello (32) found no effect of PTH status on the secretion of insulin by the isolated perfused rat pancreas. An obvious explanation for the involvement of vitamin D and its metabolites in pancreatic insulin secretion relates to the reports of the presence of a vitamin D-dependent CaBP in the pancreas of the rat (6), chick (4), pig (5), cat (9) , dog (9) , and mouse (9) .
In this respect, recent investigation by Roth et al. (8) At the present time, the biochemical function or physiological role of the vitamin D-dependent CaBP is not known even in sites of its highest cellular concentration, e.g., the intestinal epithelial cell (33) and the kidney (34) . Also, this same CaBP has been found in other locations, including the cerebellum (7), and central nervous system's Perkinge cells (35) . It is to be anticipated that further study ofthe exact mechanisms by which vitamin D or its metabolites improve insulin secretion may well provide insight into the general biological function of CaBP.
